SMHSMH·6dHealth
score+0.60
NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle
Original
NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle
“Positive framing highlights regulatory approval and milestone achievement for a specific medical treatment.”